Memorandum submitted by Dr Jean Monro and Dr Peter Julu HO 20
SUMMARY OF THE MAIN POINTS BEING MADE:
1 Homoeopathic dilutions resemble dilutions of antigens made for low-dose immunotherapy.
2 Allergy is evinced by autonomic changes which are physiologically demonstrable and measurable using the NeuroScope.
3 Low-dose immunotherapy can reverse dysautonomia. This has been demonstrated before and after depictions of physiological abnormalities.
4 Homoeopathic dilutions have been shown to mirror the provocation and nullification of symptoms in different dilutions which are evinced by low-dose immunotherapy dilutions.
5 The lymphocyte sensitivity test is described. It shows sensitivity of lymphocyte membranes when exposed to agents to which the patient is sensitive.
6 Low-dose immunotherapy can stabilise lymphocyte membranes and abort abnormal cell membrane responses, hence controlling symptoms of sensitivity.
findings described have been published, in the first instance, in a
peer-reviewed publication and, subsequently as presented to the Joint
International Neurogastroenterology and Motility Conference held in
8 Ongoing studies and observations corroborating these findings have been undertaken and are in the process of being collated.
9 There is clear, scientific evidence of the mode of action of sensitivities, allergies through the autonomic nervous system, which is the neural pathway of allergy and its control through low-dose immunotherapy.
10 As low-dose immunotherapy and homoeopathy are showing parallel effects, the findings in relation to low-dose immunotherapy are relevant to homoeopathy.
DR JEAN MONRO
I am the Medical
I have many publications to my name and regularly speak at conferences worldwide. My primary areas of interest are nutritional medicine and immunology, metabolic function and environmental medicine.
obtained his first medical degree in 1978 from
· Interactions between the autonomic nervous system and disease processes
· Non-invasive brainstem autonomic neurophysiology; he has invented and patented a machine called the NeuroScope for continuous and real time monitoring of brainstem autonomic functions
· Brainstem function in Rett syndrome - he is an active member of RettSearch, an international consortium of Rett syndrome clinical researchers.
Julu P. Vagolytic effect of diabetes mellitus. Brain 1993; v 116: pp 485-92.
Delamont RS, Julu PO, Jamal GA. Changes in a measure of cardiac vagal activity before and after epileptic seizures. Epilepsy Res 1999; v 35: pp 87-94.
Jamal GA, Hansen S, Julu PO. Low level exposures to organophosphorus esters may cause neurotoxicity. Toxicology 2002; v 181-182: pp 23-33.
Julu PO, Cooper VL, Hansen S, Hainsworth R. Cardiovascular regulation in the period preceding vasovagal syncope in conscious humans. J Physiol 2003; v 549: pp 299-311.
Julu PO, Witt Engerstrom I. Assessment of the maturity-related brainstem functions reveals the heterogeneous phenotypes and facilitates clinical management of Rett syndrome. Brain Dev 2005; v 27 (Suppl 1): S43-53.
is further information in relation to homoeopathy which can be provided, as
work has been undertaken with Dr Cyril Smith, Honorary Senior Lecturer (Retired)
We would like to invite the Committee to support the scientific basis of homoeopathy, as evinced in these observations.